SARS-CoV-2

With a grant from the Gates Foundation, CHOP researchers are working to determine the importance of mitochondria DNA variation in COVID-19 severity.

This week’s In the News features new study on measuring vision changes in patients with neurofibromatosis type 1, and other research highlights.

CHOP researchers found that a specific type of lung cell exhibits unconventional immune properties and may contribute to the outcome of respiratory viral infections.

New research suggests an association between the number of SARS COV-2 variants and the implementation of mask mandates in different states.

Researchers used deep immune profiling to better understand immune activation in children with multisystem inflammatory syndrome.

This week’s In the News features tetralogy of Fallot, CPR, stroke after SARS-CoV-2 infection, and a link between oxygen therapy and influenza.

CHOP researchers provide photos and descriptions of skin manifestations in MIS-C patients to aid healthcare providers diagnose future cases.

Researchers found that antibodies to SARS-CoV-2 efficiently cross the placenta.

Researchers in search of novel MIS-C diagnostic that could have a major impact on care of children with fever in the post-COVID era.

Paul Offit, MD, director of the Vaccine Education Center, and a world-renowned vaccine expert, discusses the pending genetic vaccines for COVID-19.